New leukemia drug may allow fewer hospital visits for kids
NCT ID NCT01574274
First seen Feb 05, 2026 · Last updated Jun 14, 2026 · Updated 17 times
Summary
This study tests a new form of chemotherapy called calaspargase pegol (SC-PEG) given every 3 weeks, compared to the standard Oncaspar given every 2 weeks, in 240 children and teens with acute lymphoblastic leukemia or lymphoma. The goal is to see if the new drug has similar side effects and drug levels while allowing fewer doses. The study also looks at whether adjusting treatment based on minimal residual disease (low levels of cancer cells) can improve cure rates, and whether giving antibiotics early can prevent serious infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier U. de Quebec
Québec, Quebec, Canada
-
Children's Hospital Boston
Boston, Massachusetts, 02215, United States
-
Columbia University Medical Center, Morgan Stanley Children's Hospital of New York-Presbyterian
New York, New York, 10032, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Hasbro Children's Hospital
Providence, Rhode Island, 02903, United States
-
Hospital Sainte Justine, University of Montreal
Montreal, Quebec, Canada
-
McMaster University
Hamilton, Ontario, Canada
-
Montefiore Medical Center
New York, New York, 10467, United States
Conditions
Explore the condition pages connected to this study.